ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HROW Harrow Inc

17.89
0.39 (2.23%)
May 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 249,439
Bid Price 15.50
Ask Price 18.39
News -
Day High 17.95

Low
7.60

52 Week Range

High
24.19

Day Low 17.07
Company Name Stock Ticker Symbol Market Type
Harrow Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.39 2.23% 17.89 00:00:08
Open Price Low Price High Price Close Price Prev Close
17.50 17.07 17.95 17.89 17.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,351 249,439 $ 17.59 $ 4,388,239 - 7.60 - 24.19
Last Trade Time Type Quantity Stock Price Currency
19:15:25 23 $ 18.25 USD

Harrow (HROW) Options Flow Summary

Overall Flow

Bullish

Net Premium

90k

Calls / Puts

100.00%

Buys / Sells

200.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

Harrow Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
873.38M 35.12M - 130.19M -24.41M -0.70 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Harrow News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HROW Message Board. Create One! See More Posts on HROW Message Board See More Message Board Posts

Historical HROW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.1118.2515.9717.00407,3921.7811.05%
1 Month10.1218.2510.0414.03571,5857.7776.78%
3 Months10.8318.259.3012.40530,9747.0665.19%
6 Months9.1718.258.720211.42465,4688.7295.09%
1 Year22.8224.197.6013.79547,346-4.93-21.60%
3 Years9.9128.255.4013.64311,0037.9880.52%
5 Years6.3328.253.3311.50264,13211.56182.62%

Harrow Description

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.

Your Recent History

Delayed Upgrade Clock